Author Question: A patient who is being treated for myasthenia gravis is receiving neostigmine, and her pulse drops ... (Read 61 times)

Yi-Chen

  • Hero Member
  • *****
  • Posts: 550
A patient who is being treated for myasthenia gravis is receiving neostigmine, and her pulse drops to 50 after the administration. Which medication should be administered to treat the bradycardia?
 
  A) Atropine
  B) Pseudoephedrine
  C) Propranolol (Inderal)
  D) Bethanechol (Urecholine)

Question 2

A patient is being observed for acute benzodiazepine withdrawal symptoms. Which of the following symptoms is characteristic of this problem?
 
  A) Bradycardia
  B) Agitation
  C) Lethargy
  D) Diaphoresis



mcabuhat

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

A
Feedback:
Atropine will reverse the muscarinic effects of cholinergic crisis. Pseudoephedrine will not affect bradycardia in this patient. Propranolol (Inderal) will not affect the bradycardia. Bethanechol will increase the bradycardia.

Answer to Question 2

B
Feedback:
Common signs and symptoms of withdrawal include increased anxiety, psychomotor agitation, insomnia, irritability, headache, tremor, and palpitations. Bradycardia, lethargy, and diaphoresis are uncharacteristic.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

Anti-aging claims should not ever be believed. There is no supplement, medication, or any other substance that has been proven to slow or stop the aging process.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library